Comparison of gadobenate dimeglumine and gadopentetate dimeglumine: a study of MR imaging and inductively coupled plasma atomic emission spectroscopy in rat brain tumors.

@article{Zhang2002ComparisonOG,
  title={Comparison of gadobenate dimeglumine and gadopentetate dimeglumine: a study of MR imaging and inductively coupled plasma atomic emission spectroscopy in rat brain tumors.},
  author={Tian Zhang and Akira Matsumura and Tetsuya Yamamoto and Fumiyo Yoshida and Tadao Nose and Nobuhiro Shimojo},
  journal={AJNR. American journal of neuroradiology},
  year={2002},
  volume={23 1},
  pages={15-8}
}
BACKGROUND AND PURPOSE After the advent of extracellular contrast media, hepatobiliary-specific gadolinium chelates were developed to improve the diagnostic value of MR imaging of the liver. Gadobenate dimeglumine (Gd-BOPTA) is a new paramagnetic contrast agent with partial biliary excretion that produces prolonged enhancement of liver parenchyma on T1-weighted images. However, whether Gd-BOPTA is useful as a contrast agent in central nervous system disease, particularly in brain tumors, is… CONTINUE READING
4 Citations
16 References
Similar Papers

Citations

Publications citing this paper.

References

Publications referenced by this paper.
Showing 1-10 of 16 references

Boron-, gadoliniumporphyrin derivatives for neutron capture therapy

  • A Matsumura, Y Shibata, K Nakagawa
  • Mishima Y, ed. Cancer Neutron Capture Therapy
  • 1996

Similar Papers

Loading similar papers…